Inactive Instrument

Highlights Endymed Ltd TEL AVIV STOCK EXCHANGE

Equities

Endymed Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	20/03	CI
Endymed Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	22/11	CI
Endymed Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29/23/29	CI
Endymed Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	24/23/24	CI
Endymed Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	30/23/30	CI
Endymed Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	24/22/24	CI
Endymed Ltd Receives FDA Approval for Marketing and Sales of its Brand-New Laser Based Hair Removal Device	20/22/20	CI
Endymed Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/22/11	CI
Endymed Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	15/22/15	CI
Endymed Ltd Appoints Bill Scott as US Subsidiary President, Endymed Inc	06/22/06	CI
Endymed Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	09/22/09	CI
Endymed Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	25/21/25	CI
Endymed Ltd Reports Earnings Results for the Full Year Ended December 31, 2020	22/21/22	CI
Endymed Ltd. Obtains FDA's First Approval of a RF Device for Home Treatment for Wrinkle Reduction	22/13/22	CI
Endymed Medical Ltd. acquired Applisonix, Ltd. (TASE: APLS) in a reverse merger transaction.	29/12/29	CI

No results for this search